0,970  0,002  AR expression inhibitor
0,969  0,004  Antiinflammatory
0,964  0,003  Carcinogenic
0,927  0,002  CYP3A4 inhibitor
0,928  0,005  Apoptosis agonist
0,914  0,003  Nitric oxide antagonist
0,839  0,005  Analgesic
0,834  0,001  Aromatase inhibitor
0,831  0,007  Antineoplastic (breast cancer)
0,728  0,018  Transcription factor NF kappa B inhibitor
0,711  0,012  Antileukemic
0,684  0,005  Tumour necrosis factor alpha release inhibitor
0,692  0,019  Antineoplastic (lung cancer)
0,624  0,010  Antiprotozoal (Plasmodium)
0,606  0,017  Antiprotozoal
0,592  0,014  Chemopreventive
0,587  0,017  Antineoplastic (ovarian cancer)
0,584  0,015  Antineoplastic (cervical cancer)
0,575  0,013  Antioxidant
0,561  0,011  Antineoplastic (glioma)
0,533  0,027  Prostate cancer treatment
0,520  0,018  Antifungal
0,508  0,010  ICAM1 expression inhibitor
0,497  0,025  Cytotoxic
0,488  0,041  Rheumatoid arthritis treatment
0,481  0,039  Antineoplastic (colorectal cancer)
0,475  0,037  Antineoplastic (colon cancer)
0,459  0,026  Antineoplastic (pancreatic cancer)
0,455  0,030  Antineoplastic (melanoma)
0,449  0,028  NOS3 expression inhibitor
0,451  0,036  Respiratory analeptic
0,427  0,014  Antihelmintic
0,423  0,019  Antineoplastic (renal cancer)
0,404  0,024  Antiparasitic
0,419  0,056  Immunosuppressant
0,361  0,014  Prostate disorders treatment
0,335  0,021  Hepatoprotectant
0,319  0,006  LDLR expression enhancer
0,354  0,050  Analeptic
0,343  0,039  Antineoplastic (lymphoma)
0,331  0,048  NOS2 expression inhibitor
0,335  0,064  Caspase 3 stimulant
0,279  0,026  Contraceptive
0,296  0,045  Antimitotic
0,313  0,070  Antineoplastic (brain cancer)
0,311  0,076  Immunomodulator
0,288  0,056  Cardiovascular analeptic
0,279  0,054  Antineoplastic (glioblastoma multiforme)
0,222  0,004  Opioid kappa receptor agonist
0,229  0,017  Antineoplastic antibiotic
0,218  0,030  Heat shock protein 90 antagonist
0,252  0,088  UGT2B4 substrate
0,268  0,110  Apoptosis antagonist
0,223  0,069  Psychostimulant
0,214  0,063  UGT1A1 substrate
0,155  0,005  Na+ K+ transporting ATPase inhibitor
0,185  0,038  Antifungal enhancer
0,190  0,047  UGT2B15 substrate
0,209  0,065  UDP-glucuronosyltransferase substrate
0,216  0,078  Antiviral (HIV)
0,196  0,059  Lipocortins synthesis antagonist
0,203  0,070  Platelet adhesion inhibitor
0,193  0,064  UGT2B7 substrate
0,206  0,089  UGT1A6 substrate
0,140  0,024  Anabolic
0,171  0,055  Lipid peroxidase inhibitor
0,176  0,067  Prostatic (benign) hyperplasia treatment
0,145  0,040  Microtubule formation inhibitor
0,212  0,108  Antineoplastic (sarcoma)
0,164  0,063  UGT2B9 substrate
0,139  0,044  Contraceptive female
0,160  0,065  Antiviral (Influenza A)
0,177  0,082  P-glycoprotein inhibitor
0,202  0,121  Proliferative diseases treatment
0,217  0,137  Hepatic disorders treatment
0,193  0,114  Antineoplastic (liver cancer)
0,142  0,063  Farnesoid X receptor antagonist
0,154  0,076  Melanin inhibitor
0,129  0,052  Alcohol dehydrogenase substrate
0,087  0,010  Lipocortins synthesis agonist
0,104  0,031  Opioid kappa receptor antagonist
0,202  0,131  Chemoprotective
0,146  0,083  Interferon gamma antagonist
0,096  0,038  Antiprotozoal activity enhancer
0,081  0,024  Androgen agonist
0,102  0,046  SULT1E1 substrate
0,129  0,075  CC chemokine 6 receptor antagonist
0,061  0,011  RNA-directed RNA polymerase stimulant
0,161  0,112  Embryotoxic
0,187  0,149  UGT1A9 substrate
0,108  0,071  Protein-tyrosine phosphatase 1B inhibitor
0,193  0,160  Hypoxia-inducible factor 1 alpha inhibitor
0,060  0,030  Estrogen agonist
0,054  0,025  Potassium channel Kv1.3 blocker
0,135  0,107  Arachidonic acid antagonist
0,058  0,032  Opioid agonist
0,084  0,060  Antineoplastic alkaloid
0,058  0,037  Postcoital contraceptive
0,135  0,115  Interleukin 6 antagonist
0,224  0,206  Transcription factor inhibitor
0,038  0,022  Estrogen receptor alpha agonist
0,036  0,021  Tubulin agonist
0,064  0,049  p38 MAP kinase inhibitor
0,025  0,010  Corticosteroid-like
0,210  0,195  TNF expression inhibitor
0,046  0,033  Microtubule stabilization
0,038  0,026  Glucose-6-phosphate dehydrogenase inhibitor
0,138  0,130  Teratogen
0,026  0,019  Toll-Like receptor 4 agonist
0,079  0,072  T cell inhibitor
0,110  0,106  Antihemorrhagic
0,195  0,192  CYP3A4 substrate
0,142  0,140  Systemic lupus erythematosus treatment
0,102  0,100  Antiacne
0,072  0,071  Glycine receptor antagonist

